Thrombolytic therapy for central venous catheter occlusion

Jacquelyn L Baskin1, Ulrike Reiss, Judith A Wilimas

  • 1Division of Hematology and Oncology, Children’s Hospital Los Angeles, Los Angeles, CA 90027, USA. jbaskin13@hotmail.com

Haematologica
|December 20, 2011
PubMed

Insights

Thrombolytic agents effectively clear central venous catheter obstructions. Newer medications show promise for faster and more effective treatment of these common catheter complications.

Area of Science:

  • Vascular Access Management
  • Pharmacological Interventions
  • Medical Device Complications

Background:

  • Central venous catheters (CVCs) are vital for chronic illness care but prone to obstructions.
  • Catheter obstructions can delay critical treatments and necessitate device removal.

Purpose of the Study:

  • To review the efficacy of thrombolytic therapy for central venous catheter obstruction.
  • To assess clearance rates and time to clearance for various thrombolytic agents.

Main Methods:

  • Literature review of Medline searches for central venous catheter obstruction and thrombolytic treatment.
  • Assessment of thrombolytic therapy efficacy, clearance rates, and time to clearance.

Main Results:

  • Alteplase achieves 86% overall clearance; newer agents like reteplase (95%), tenecteplase (83%), and alfimeprase (80%) show high efficacy.
  • Recombinant urokinase demonstrated 73% overall clearance and reduced occlusion incidence (4-23%) with prophylactic use.
  • Alfimeprase provided rapid clearance, resolving 40% of occlusions within 5 minutes.

Conclusions:

  • Thrombolytic agents are effective in resolving most central venous catheter occlusions.
  • Emerging thrombolytic agents may offer superior speed and efficacy compared to current options.
  • Further randomized comparative studies are required to establish optimal thrombolytic management strategies.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...